Remembering Norm Macdonald: Understanding Leukemia

Nine years, told to almost nobody

Norm Macdonald anchored Weekend Update on Saturday Night Live and built a career on deadpan delivery. BBC News reported that he died at 61, nine years after a cancer diagnosis his family and representatives only disclosed afterward.

His producing partner Lori Jo Hoekstra explained the reasoning. "He was most proud of his comedy. He never wanted the diagnosis to affect the way the audience or any of his loved ones saw him. Norm was a pure comic," she said.

CBC News reported that his brother Neil said he died in Los Angeles from leukemia, diagnosed "a long time ago." Neil described the choice too. "He took great pains to conceal it from everybody but family. Cancer's a roller-coaster. We hoped that he would live longer than he did, but it took a turn for the worst last month, and he went into hospital and never came out."

The specific type of leukemia was never made public, and this page will not guess at it. That absence is a useful starting point, because leukemia is four largely separate diseases wearing one name.

Two questions, four answers

Blood cells are made in bone marrow, the factory inside your bones. A stem cell there becomes a red cell that carries oxygen, a platelet that clots, or a white cell that fights infection. Leukemia is cancer of that white cell production line.

The National Cancer Institute organizes adult leukemia by two questions. Is it acute or chronic, meaning fast or slow? And is it myeloid or lymphoid, meaning which branch of white cell it came from?

Those two questions produce four main diseases: acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia. Each has its own treatment guidance, its own drugs, and its own expected course.

For 2026 the American Cancer Society projects 67,790 new leukemia cases of all types and 23,910 deaths in the United States, and SEER, the federal cancer surveillance program, publishes that projection on its own page. The rate of new cases is 14.7 per 100,000 people per year, and the death rate is 5.7. Five-year relative survival across all leukemias, for diagnoses from 2016 through 2022, is 68.6 percent. SEER notes that although leukemia is among the most common childhood cancers, it most often occurs in older adults.

What acute means

Acute myeloid leukemia is the version that moves fast. NCI describes it as blood cancer arising from "clonal expansion of myeloid hematopoietic precursors in the bone marrow." Immature cells called blasts multiply and crowd out normal production, so infection-fighting cells, red cells, and platelets all fall at once.

The tempo is measurable. NCI notes that symptoms of acute leukemia "often arise over a 4- to 6-week period before diagnosis," presenting as weakness, fever, and bleeding. The median age at diagnosis is 69, and it is uncommon before 45.

Diagnosis rests on a threshold. NCI states that "a peripheral blood or bone marrow blast count of 20% or greater is required to make the diagnosis," with a few exceptions for specific chromosome rearrangements. Flow cytometry reads the proteins on the cell surface, because appearance under a microscope is not enough to tell the types apart.

SEER reports five-year relative survival for AML at 33.4 percent, among people diagnosed from 2016 through 2022. NCI reports that roughly 60 to 70 percent of adults reach complete remission after induction chemotherapy, and that more than 25 percent survive three or more years and may be cured.

What chronic means

Chronic lymphocytic leukemia is the opposite temperament. The American Cancer Society puts new cases at 22,760 and deaths at 4,350 in the United States for 2026, down from the 23,690 and 4,460 it gave for 2025 that NCI's PDQ summary repeats, and NCI describes the disease as progressing from "an indolent lymphocytosis without other evident disease," meaning a raised lymphocyte count with nothing else wrong.

Many people with CLL feel entirely well for years. NCI's guidance includes a whole section on treatment of asymptomatic CLL, and for many the answer is monitoring rather than drugs.

NCI also raises a caution that applies more broadly. As blood tests grew more sensitive, a precursor condition called monoclonal B-cell lymphocytosis turned up in a substantial share of older adults. NCI warns that finding it early "may unnecessarily worry or result in therapy for some patients who would have remained undiagnosed in their lifetime, a circumstance known as overdiagnosis or pseudodisease."

One complication is worth naming. In 2 to 10 percent of patients, CLL transforms into an aggressive lymphoma, called Richter transformation. Modern CLL treatment now leans on BTK inhibitors and BCL2 inhibitors rather than traditional chemotherapy, and NCI notes that older prognostic scoring systems may need revalidating because of them.

When to get checked

Leukemia signals are ordinary complaints, which is exactly why they get dismissed. The pattern to notice is several of them together over weeks.

• Fatigue that is new and keeps worsening
• Breathlessness on stairs you used to manage
• Fevers or infections that keep coming back
• Bruises you cannot account for
• Bleeding gums, nosebleeds, or tiny red skin spots
• Drenching night sweats or unplanned weight loss
• Painless swollen lymph nodes lasting over four weeks

A complete blood count is inexpensive and fast. If several of these are present together, asking for one is reasonable.

Privacy is a legitimate medical choice

Macdonald told almost no one for nine years. That is worth defending rather than explaining away.

There is no obligation to disclose a diagnosis to an employer, an audience, or anyone beyond the people whose help you want. Public figures who share their diagnoses do real good, and public figures who do not are not withholding anything owed.

What his family described is also common. A long illness is rarely a straight line, and the phrase his brother used, a roller-coaster, matches how chronic and relapsing blood cancers actually behave.

What the numbers mean, and do not

Every figure above describes a group. SEER attaches the caution itself: "Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient."

That applies with unusual force to leukemia, because the four main types have such different courses that a combined statistic describes almost nobody precisely. If someone you love is diagnosed, the useful question is not what leukemia survival looks like. It is which leukemia this is, and what the numbers look like for that one.

Sources

• https://www.bbc.co.uk/news/world-us-canada-58565272
• https://www.cbc.ca/news/entertainment/norm-macdonald-dies-1.6175474
• https://www.cancer.gov/types/leukemia
• https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq
• https://www.cancer.gov/types/leukemia/hp/cll-treatment-pdq
• https://seer.cancer.gov/statfacts/html/leuks.html
• https://seer.cancer.gov/statfacts/html/amyl.html
• https://www.cancer.org/research/cancer-facts-statistics.html